TY  - JOUR
PY  - 2022//
TI  - Wrong study window to assess the full impacts of legalization on pediatric cannabis exposures
JO  - Pediatrics
A1  - Myran, Daniel
A1  - Finkelstein, Yaron
SP  - ePub
EP  - ePub
VL  - ePub
IS  - ePub
N2  - Topics:  cannabis, exposure, marijuana    We thank Yeung and colleagues for an important contribution to the literature on harms and potential health effects to young children and older adolescents after legalization of recreational, or nonmedical, cannabis in Canada.1     We are writing to highlight an important clarification to the regulatory policies under study, to help readers contextualize the observations in a more accurate and granular way. Canada, including Alberta, took a 2 staged approach to legalization of recreational cannabis. Initially, in October 2018, flower-based products and oils were legalized for sale. One year later cannabis industry manufacturers were allowed to apply for licenses to produce and sell a wider variety of products, including Tetrahydrocannabinol (THC) containing edibles, drinks, and concentrates.     The authors noted that cannabis edibles were legalized in Canada in October 2019. Critically, however, these products did not become available on the market in most Canadian provinces, including Alberta, until January 2020.2 Previous...<p />  <p>Language: en</p>
LA  - en
SN  - 0031-4005
UR  - http://dx.doi.org/10.1542/peds.2022-057638A
ID  - ref1
ER  -